Basic mechanisms in vascular headache
- PMID: 2175382
Basic mechanisms in vascular headache
Abstract
To better understand and treat painful conditions, one needs to identify the cause, discover the source, and develop knowledge of peripheral and central pain transmission; headaches are no exception. The development of appropriate animal models is important. Accordingly, we have reviewed the anatomy, neurochemistry, electrophysiology, and pharmacology of the trigeminovascular system in experimental animals and emphasized whenever possible the relevance of this final common pathway to migraine, cluster, and other headache syndromes in humans. For example, based on recent anatomic dissections, the pericarotid cavernous sinus plexus was suggested as an important focus to investigate cluster headache pathophysiology. This plexus is an anatomic point of convergence for the nerves giving rise to the signs of sympathetic and parasympathetic activity and sensory symptoms that develop in cluster patients. As in other nociceptive systems, trigeminovascular axons assume at least two important roles. One concerns the transmission of nociceptive information. Electrophysiologic evidence supports the trigeminal nucleus caudalis as an important site for the convergence of visceral (vessel) and somatic (forehead) inputs to mediate the referral of vascular pain to superficial tissues. A second important role concerns the initiation of local increases in blood flow and enhanced protein permeability (sterile inflammation) via the axonal release of vasoactive neuropeptides. Plasma extravasation develops within the dura mater following trigeminal stimulation. Extravasation can be blocked by the administration of ergot alkaloids or sumatriptan, a new serotonin-like agonist, and a prejunctional (neuronal) mechanism of action for these drugs (such as blockade of release) was suggested based on experimental evidence. Whether vasoconstriction also relates to the therapeutic efficacy remains to be determined. As in other organ systems, real or threatened tissue injury provides an important stimulus for depolarizing sensory fibers. The stimulus may come from external conditions such as reduced blood flow or hypoglycemia. The brain may also possess intrinsic neuronal mechanisms by which nociceptors may be synthesized (e.g., glutamate-induced neurotoxicity, seizures). Molecules of relevance include bradykinin, prostaglandins, leukotrienes, and potassium. Experimental evidence was presented demonstrating that the trigeminal nerve mediates hyperemia within cortical gray matter by axon-reflex like mechanisms. An important role for this nerve was established during the hyperemic period of recirculation after ischemia or during severe hypertension above the limits of autoregulation.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Pain mechanisms underlying vascular headaches. Progress Report 1989.Rev Neurol (Paris). 1989;145(3):181-93. Rev Neurol (Paris). 1989. PMID: 2664974 Review.
-
Oxygen inhibits neuronal activation in the trigeminocervical complex after stimulation of trigeminal autonomic reflex, but not during direct dural activation of trigeminal afferents.Headache. 2009 Sep;49(8):1131-43. doi: 10.1111/j.1526-4610.2009.01501.x. Headache. 2009. PMID: 19719541
-
Neurogenic inflammation in the pathophysiology and treatment of migraine.Neurology. 1993 Jun;43(6 Suppl 3):S16-20. Neurology. 1993. PMID: 8389008 Review.
-
The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation.J Cereb Blood Flow Metab. 1999 Feb;19(2):115-27. doi: 10.1097/00004647-199902000-00001. J Cereb Blood Flow Metab. 1999. PMID: 10027765 Review.
-
Plasma protein extravasation induced in the rat dura mater by stimulation of the parasympathetic sphenopalatine ganglion.Exp Neurol. 1997 Oct;147(2):389-400. doi: 10.1006/exnr.1997.6614. Exp Neurol. 1997. PMID: 9344563
Cited by
-
Patient outcome in migraine prophylaxis: the role of psychopharmacological agents.Patient Relat Outcome Meas. 2010 Jul;1:107-18. doi: 10.2147/PROM.S9742. Epub 2010 Sep 17. Patient Relat Outcome Meas. 2010. PMID: 22915957 Free PMC article.
-
Acute treatment of migraines.CNS Drugs. 2012 Oct 1;26(10):823-39. doi: 10.2165/11635440-000000000-00000. CNS Drugs. 2012. PMID: 22823482 Review.
-
Anandamide induces cardiovascular and respiratory reflexes via vasosensory nerves in the anaesthetized rat.Br J Pharmacol. 2001 Oct;134(3):655-63. doi: 10.1038/sj.bjp.0704296. Br J Pharmacol. 2001. PMID: 11588121 Free PMC article.
-
Migraine pathogenesis and state of pharmacological treatment options.BMC Med. 2009 Nov 16;7:71. doi: 10.1186/1741-7015-7-71. BMC Med. 2009. PMID: 19917094 Free PMC article. Review.
-
Progressive ataxia due to a missense mutation in a calcium-channel gene.Am J Hum Genet. 1997 Nov;61(5):1078-87. doi: 10.1086/301613. Am J Hum Genet. 1997. PMID: 9345107 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Research Materials